By Hank Schultz, Elaine Watson and Elizabeth Crawford
A report on CBD delivered by FDA Commissioner Dr Stephen Hahn, MD, was seen by food and dietary supplement industry stakeholders as offering little hope of a timely regulatory solution for the ingredient.
FDA Commissioner Dr Stephen Hahn, MD, in a speech on Wednesday, said that despite its continued concern about insufficient safety data, the FDA has no plans to try to shut down the CBD markets. Hahn said that would amount to a “fool’s game.”
There has been a lot of talk over the years about there being ‘two’ dietary supplement industries. One that plays by the rules, one that doesn’t. But it’s wise not to forget in that discussion the entrepreneurial drive that made this a thriving industry...
Herbalife reported a 3% rise in sales for its full year, recording $4.9 billion in revenue. The increase was achieved even with sharp declines in China attributable to that country’s regulatory crackdown on multi level marketing companies.
Provo, UT-based MLM NuSkin saw year-over-year revenues fall by 10% as a result of the continued regulatory pressure in China. The COVID-19 disease outbreak is expected to depress results even further in the coming year.
The Natural Products Association credits a grass roots pressure campaign with forestalling the advance of two troublesome Illinois State measures. One affects weight management supplements and the other CBD businesses.